BIOTECH rice—the insect resistant variety and Golden
Rice—will lead the new genetically modified crops for
commercial use in the second wave (2006 to 2015) of market availability,
according to the International Service for the Acquisition of
Agribiotech Applications (ISAAA).
Dr. Randy Hautea, ISAAA global coordinator and its SEAsiaCenter
director, told reporters that Bacillus thuringiensis (Bt)-resistant
rice from China “may be available within 24 months,”
or between now and 2010, and Golden Rice by 2012.
Hautea made the disclosure last week at the press conference
on the global launching of the 2008 Global Status of Commercialized
Biotech/GM (Genetically Modified) Crops report authored by Dr.
Clive James, founder and chairman of ISAAA board of directors.
Bt rice is “extensively field tested in China and awaiting
approval by the Chinese regulatory authorities” for commercialization,
the report said.
Golden Rice—or genetically biofortified rice with beta
carotene that produces vitamin A—is being field-tested
at the International Rice Research Institute in Los Baños,
Laguna. Its adoption for the Philippines is being done by the
Philippine Rice Research Institute with two other traits incorporated
in the rice—tungro virus and bacterial blight resistance.
The ISAAA report recognized biotech rice as “the most
important of the new biotech crops that are now ready for adoption.”
This development is of great significance because rice is the
most important food crop in the world, especially for the poor,
aside from answering the current food security problem, James
said.
“[More than] 90 percent of rice is grown and consumed
in Asia by some of the poorest people in the world—the
250-million Asian households whose resource-poor rice farmers
cultivate on average a meager half a hectare of rice,”
the ISAAA report said.
Bt eggplant may be available as the first biotech-food crop
in India within the next 12 months, the ISAAA report said. India
is the fourth-largest producer of biotech crops with GM cotton
planted in 7.6 million hectares.
Other crops that are expected to be available in the market
before 2015 are potatoes with pest and/or disease resistance
and modified quality for industrial use; sugar cane with quality
and agronomic traits; and disease-resistant bananas.
Biotech vegetable crops—such as tomato, broccoli, cabbage
and okra—that would require reduced amount of insecticides
are being developed, along with propoor biotech cassava, sweet
potato, pulses and ground nut, the report said.
Hautea noted the significance of 2015 as the end of the second
decade when new biotech crops are available, because it is the
target year under the Millennium Development Goals when a secure
supply of affordable food is ensured and poverty and hunger
have been reduced by 50 percent.
James said in the report that 2 billion acres or 800 million
hectares were planted to biotech crops from 1996 to 2008, and
that 13.3-million farmers in 25 countries planted biotech crops
in 125 million hectares last year.
Among the notable developments, the report said, was the adoption
of biotech crops in the African countries of Egypt (700 hectares
of Bt corn) and Burkina Faso (8,500 hectares of Bt cotton),
joining South Africa in biotech farming which, since 1998, has
planted biotech cotton, corn and soybean.
“...Africa is considered the ‘final frontier’
for biotech crops as it has perhaps the greatest need and most
to gain,” ISAAA said.
In the Philippines, 200,000 small farmers planted about 350,000
hectares of Bt corn farms in 2008.
A socioeconomic impact study cited by ISAAA said that small
farmers in the Philippines earn an additional income of P7,482
a hectare in the dry season and P7,080 in the wet season from
Bt corn in crop year 2003-2004.
Multiawarded biotech corn farmer Lydia Lapastora of Isabela
province said in the same media briefing she netted P11,021
a hectare from planting GM corn compared with the traditional
varieties.
Bt corn is the only transgenic crop commercially planted in
the Philippines. However, 46 other products with GM traits,
such as soya and canola, are allowed to be imported into the
country, said Dr. Emil Javier, president of the National Academy
of Science and Technology, in the same briefing.
Javier said in a speech that in order for the Philippines to
hasten the development of biotech crops, it should “sharpen
[its] focus” on transgenic traits already commercialized
by other countries and apply them in local crops so that it
could “reap the full benefits of plant biotechnology with
the resources and opportunities at hand.”
He cited as example the development of Bt eggplant, and ring-spot
virus-resistant papaya and delayed-ripening papaya in the country.
“We must put in more resources and speed up and scale
up their testing and commercialization,” he urged.
He also raised the need for more lawyers and technical people
with “business savvy” that would sort out the legal
and financial applications of biotech technologies that could
be applied in the country.
He said almost all of the country’s agribiotech research
and development experts are in public hands but they do not
have this kind of expertise in house.
“We must explore new ways of sourcing these expertise
from the private sector to free our scientists from these roles
they have no aptitude for, in the first place. We need lawyers
and ‘techies’ to negotiate with foreign technology
owners as well as with domestic private investors who will put
up the capital and manage the enterprise,” Javier said.
Besides the 25 countries growing biotech crops, Hautea said,
30 countries are not growing but importing such products, and
three to four countries “unofficially” (not legally
sanctioned by their governments) grow GM crops.
The countries planting biotech crops are (according to hectarage):
United States covering 62.5 million hectares with soybean, corn,
cotton, canola, squash, papaya, alfalfa and sugar beet; Argentina,
21 million (soybean, corn and cotton); Brazil, 15.8 million
(soybean, corn and cotton); India, 7.6 million (cotton); Canada,
7.6 million (canola, corn, soybean and sugar beet); China, 3.8
million (cotton, tomato, poplar, petunia, papaya and sweet pepper);
Paraguay, 2.7 million (soybean); South Africa, 1.8 million (corn,
soybean and cotton); Uruguay, 700,000 (soybean and corn); Bolivia,
600,000 (soybean); Philippines, 400,000 (corn); Australia, 200,000
(cotton, canola and carnation); Mexico, 100,000 (cotton, soybean);
Spain, 100,000 (corn);
Those planting biotech crops in less than 100,000 hectares
are Chile with corn, soybean and canola; Colombia (cotton and
carnation); Honduras (corn); Burkina Faso (cotton); and Czech
Republic, Romania, Portugal, Germany, Poland, Slovakia and Egypt
with GM corn.
By 2015, the ISAAA projection is that from the current 25 countries
40 more will plant biotech crops with 20 million or more farmers
involved in about 200 million hectares.